Stay updated on Nivolumab in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Nivolumab in Hodgkin Lymphoma Clinical Trial page
- Check2 days agoChange DetectedThe study page now states that no participants are being sought and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated revision note (Revision: v3.6.0). The Intervention/Treatment header formatting was adjusted (Intervention/Treatment added and Intervention / Treatment removed).SummaryDifference0.3%

- Check9 days agoChange DetectedThe page now shows Revision: v3.5.5, indicating a minor update to the study record rather than substantive content changes.SummaryDifference0.0%

- Check17 days agoChange DetectedA Publications section was added, listing a Haematologica article about Nivolumab with or without vinblastine for elderly Hodgkin lymphoma, and noting that such publications are automatically filled from PubMed.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now references revision v3.5.4 instead of v3.5.3, signaling a backend/UI update without changes to the trial details or core content.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page’s footer shows an updated site/system software revision from v3.5.2 to v3.5.3, without altering the underlying study details.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.